Global Prophylactic Human Vaccine Sales Market Report Forecast 2017-2021

April 2017 | 109 pages | ID: G5031F03D57EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 PROPHYLACTIC HUMAN VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Classification of Prophylactic Human Vaccine
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Prophylactic Human Vaccine
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prophylactic Human Vaccine Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Prophylactic Human Vaccine (2012-2021)
  1.5.1 Global Prophylactic Human Vaccine Sales and Growth Rate (2012-2021)
  1.5.2 Global Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON PROPHYLACTIC HUMAN VACCINE INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 PROPHYLACTIC HUMAN VACCINE MANUFACTURING COST ANALYSIS

3.1 Prophylactic Human Vaccine Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Prophylactic Human Vaccine Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL PROPHYLACTIC HUMAN VACCINE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Prophylactic Human Vaccine Market Competition by Manufacturers
  5.1.1 Global Prophylactic Human Vaccine Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Prophylactic Human Vaccine Revenue and Share by Manufacturers (2012-2017)
5.2 Global Prophylactic Human Vaccine (Volume and Value) by Type
  5.5.1 Global Prophylactic Human Vaccine Sales and Market Share by Type (2012-2017)
  5.5.2 Global Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
5.3 Global Prophylactic Human Vaccine (Volume and Value) by Regions
  5.3.1 Global Prophylactic Human Vaccine Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Prophylactic Human Vaccine Revenue and Market Share by Regions (2012-2017)
5.4 Global Prophylactic Human Vaccine (Volume) by Application

6 UNITED STATES PROPHYLACTIC HUMAN VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 United States Prophylactic Human Vaccine Sales and Value (2012-2017)
  6.1.1 United States Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
  6.1.2 United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
  6.1.3 United States Prophylactic Human Vaccine Sales Price Trend (2012-2017)
6.2 United States Prophylactic Human Vaccine Sales and Market Share by Manufacturers
6.3 United States Prophylactic Human Vaccine Sales and Market Share by Type
6.4 United States Prophylactic Human Vaccine Sales and Market Share by Application

7 CHINA PROPHYLACTIC HUMAN VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 China Prophylactic Human Vaccine Sales and Value (2012-2017)
  7.1.1 China Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
  7.1.2 China Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
  7.1.3 China Prophylactic Human Vaccine Sales Price Trend (2012-2017)
7.2 China Prophylactic Human Vaccine Sales and Market Share by Manufacturers
7.3 China Prophylactic Human Vaccine Sales and Market Share by Type
7.4 China Prophylactic Human Vaccine Sales and Market Share by Application

8 EUROPE PROPHYLACTIC HUMAN VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Prophylactic Human Vaccine Sales and Value (2012-2017)
  8.1.1 Europe Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
  8.1.2 Europe Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Prophylactic Human Vaccine Sales Price Trend (2012-2017)
8.2 Europe Prophylactic Human Vaccine Sales and Market Share by Manufacturers
8.3 Europe Prophylactic Human Vaccine Sales and Market Share by Type
8.4 Europe Prophylactic Human Vaccine Sales and Market Share by Application

9 JAPAN PROPHYLACTIC HUMAN VACCINE (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Prophylactic Human Vaccine Sales and Value (2012-2017)
  9.1.1 Japan Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
  9.1.2 Japan Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Prophylactic Human Vaccine Sales Price Trend (2012-2017)
9.2 Japan Prophylactic Human Vaccine Sales and Market Share by Manufacturers
9.3 Japan Prophylactic Human Vaccine Sales and Market Share by Type
9.4 Japan Prophylactic Human Vaccine Sales and Market Share by Application

10 GLOBAL PROPHYLACTIC HUMAN VACCINE MANUFACTURERS ANALYSIS

10.1 Bavarian Nordic A/S
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 BiondVax Pharmaceuticals Ltd
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Bharat Biotech International Limited
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 GlaxoSmithKline
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Hualan Biological Engineering
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Janssen Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 MedImmune
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Merck
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Pfizer
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL PROPHYLACTIC HUMAN VACCINE MARKET FORECAST (2017-2021)

13.1 Global Prophylactic Human Vaccine Sales, Revenue Forecast (2017-2021)
13.2 Global Prophylactic Human Vaccine Sales Forecast by Regions (2017-2021)
13.3 Global Prophylactic Human Vaccine Sales Forecast by Type (2017-2021)
13.4 Global Prophylactic Human Vaccine Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccine
Table Classification of Prophylactic Human Vaccine
Figure Global Sales Market Share of Prophylactic Human Vaccine by Type in 2015
Table Applications of Prophylactic Human Vaccine
Figure Global Sales Market Share of Prophylactic Human Vaccine by Application in 2015
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)
Figure China Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)
Figure Europe Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)
Figure Japan Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)
Figure Global Prophylactic Human Vaccine Sales and Growth Rate (2012-2021)
Figure Global Prophylactic Human Vaccine Revenue and Growth Rate (2012-2021)
Table Global Prophylactic Human Vaccine Sales of Key Manufacturers (2012-2017)
Table Global Prophylactic Human Vaccine Sales Share by Manufacturers (2012-2017)
Figure 2015 Prophylactic Human Vaccine Sales Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Sales Share by Manufacturers
Table Global Prophylactic Human Vaccine Revenue by Manufacturers (2012-2017)
Table Global Prophylactic Human Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 Global Prophylactic Human Vaccine Revenue Share by Manufacturers
Table Global Prophylactic Human Vaccine Sales and Market Share by Type (2012-2017)
Table Global Prophylactic Human Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure Global Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
Table Global Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure Global Prophylactic Human Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Prophylactic Human Vaccine Sales and Market Share by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Prophylactic Human Vaccine by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Sales Growth Rate by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Revenue and Market Share by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Revenue Growth Rate by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Sales and Market Share by Application (2012-2017)
Table Global Prophylactic Human Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Prophylactic Human Vaccine by Application (2012-2017)
Figure Global Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Price Trend (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Manufacturers (2012-2017)
Table United States Prophylactic Human Vaccine Market Share by Manufacturers (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Type (2012-2017)
Table United States Prophylactic Human Vaccine Market Share by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Application (2012-2017)
Table United States Prophylactic Human Vaccine Market Share by Application (2012-2017)
Figure China Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
Figure China Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
Figure China Prophylactic Human Vaccine Sales Price Trend (2012-2017)
Table China Prophylactic Human Vaccine Sales by Manufacturers (2012-2017)
Table China Prophylactic Human Vaccine Market Share by Manufacturers (2012-2017)
Table China Prophylactic Human Vaccine Sales by Type (2012-2017)
Table China Prophylactic Human Vaccine Market Share by Type (2012-2017)
Table China Prophylactic Human Vaccine Sales by Application (2012-2017)
Table China Prophylactic Human Vaccine Market Share by Application (2012-2017)
Figure Europe Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
Figure Europe Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
Figure Europe Prophylactic Human Vaccine Sales Price Trend (2012-2017)
Table Europe Prophylactic Human Vaccine Sales by Manufacturers (2012-2017)
Table Europe Prophylactic Human Vaccine Market Share by Manufacturers (2012-2017)
Table Europe Prophylactic Human Vaccine Sales by Type (2012-2017)
Table Europe Prophylactic Human Vaccine Market Share by Type (2012-2017)
Table Europe Prophylactic Human Vaccine Sales by Application (2012-2017)
Table Europe Prophylactic Human Vaccine Market Share by Application (2012-2017)
Figure Japan Prophylactic Human Vaccine Sales and Growth Rate (2012-2017)
Figure Japan Prophylactic Human Vaccine Revenue and Growth Rate (2012-2017)
Figure Japan Prophylactic Human Vaccine Sales Price Trend (2012-2017)
Table Japan Prophylactic Human Vaccine Sales by Manufacturers (2012-2017)
Table Japan Prophylactic Human Vaccine Market Share by Manufacturers (2012-2017)
Table Japan Prophylactic Human Vaccine Sales by Type (2012-2017)
Table Japan Prophylactic Human Vaccine Market Share by Type (2012-2017)
Table Japan Prophylactic Human Vaccine Sales by Application (2012-2017)
Table Japan Prophylactic Human Vaccine Market Share by Application (2012-2017)
Table Bavarian Nordic A/S Basic Information List
Table Bavarian Nordic A/S Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S Prophylactic Human Vaccine Global Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information List
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information List
Table Bharat Biotech International Limited Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bharat Biotech International Limited Prophylactic Human Vaccine Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hualan Biological Engineering Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Prophylactic Human Vaccine Global Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Prophylactic Human Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Prophylactic Human Vaccine Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure Global Prophylactic Human Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Global Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table Global Prophylactic Human Vaccine Sales Forecast by Regions (2017-2021)
Table Global Prophylactic Human Vaccine Sales Forecast by Type (2017-2021)
Table Global Prophylactic Human Vaccine Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio